Compound danshen dripping pills

DRUG3 trials

Sponsors

Tasly Pharmaceuticals, Inc., China National Center for Cardiovascular Diseases

Conditions

Acute Mountain SicknessCoronary Arterial Disease (CAD)Non-proliferative Diabetic Retinopathy

Phase 1

Study of Compound Danshen Dripping Pills to Treat Acute Mountain Sickness

CompletedNCT03270787

Tasly Pharmaceuticals, Inc.Acute Mountain Sickness

Start: 2016-06-24End: 2017-07-13Updated: 2017-09-01

Phase 3

Phase III Study of Compound Danshen Dripping Pills to Treat Diabetic Retinopathy

Tasly Pharmaceuticals, Inc.Non-proliferative Diabetic Retinopathy

Start: 2013-05-31End: 2017-12-31Target: 480Updated: 2017-03-21

Phase 4

Pre-trial of Clinical Trial of Traditional Chinese Medicine Treatment for Elderly Patients With Coronary Heart Disease Who Are Still Symptomatic After Optimal Medical Treatment

RecruitingNCT07041359

China National Center for Cardiovascular DiseasesCoronary Arterial Disease (CAD)

Start: 2025-08-18End: 2026-12-31Target: 120Updated: 2025-09-29

Related Papers

Efficacy of Danshen (Salvia miltiorrhiza) Dripping Pills for Prevention of Acute Mountain Sickness: A Randomized, Double-Blind, Placebo-Controlled Trial

Pakistan Journal of Zoology2020-01-012 citations